Rescue of dysfunctional autophagy attenuates hyperinflammatory responses from cystic fibrosis cells

Journal of Immunology

Volumn 190, Issue 3, 2013, Pages 1227-1238

  Mayer, Matthew L ^a   Blohmke, Christoph J ^a   Falsafi, Reza ^a   Fjell, Chris D ^a   Madera, Laurence ^b   Turvey, Stuart E ^b   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BC CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE MONOPHOSPHATE ACTIVATED PROTEIN KINASE; CELL PROTEIN; FLAGELLIN; INNATE DEFENSE REGULATOR 1018; PEPTIDE; PROTEIN FLIC; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN LC3; PROTEIN LC3-II; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL FUSION; CHILD; CLINICAL ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; LUNG ALVEOLUS CELL; LYSOSOME; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN FUNCTION; SCHOOL CHILD; SIGNAL TRANSDUCTION;

ANTI-INFLAMMATORY AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; AUTOPHAGY; CELL LINE; CHILD; CYSTIC FIBROSIS; CYTOKINES; EPITHELIAL CELLS; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; LUNG; LYSOSOMES; MACROLIDES; MICROTUBULE-ASSOCIATED PROTEINS; MODELS, IMMUNOLOGICAL; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TRANSCRIPTION, GENETIC;

EID: 84872735966     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201404     Document Type: Article

References (76)

1. Ratjen, F., and G. Doring. 2003. Cystic fibrosis. Lancet 361: 681-689. (Pubitemid 36246556)
2. Rottner, M., J. M. Freyssinet, and M. C. Marti'nez. 2009. Mechanisms of the noxious inflammatory cycle in cystic fibrosis. Respir. Res. 10: 23.
3. Machen, T. E. 2006. Innate immune response in CF airway epithelia: Hyperinflammatory? Am. J. Physiol. Cell Physiol. 291: C218-C230. (Pubitemid 44148143)
4. Stoltz, D. A., D. K. Meyerholz, A. A. Pezzulo, S. Ramachandran, M. P. Rogan, G. J. Davis, R. A. Hanfland, C. Wohlford-Lenane, C. L. Dohrn, J. A. Bartlett, et al. 2010. Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci. Transl. Med. 2: 29ra31.
5. Nichols, D. P., M. W. Konstan, and J. F. Chmiel. 2008. Anti-inflammatory therapies for cystic fibrosis-related lung disease. Clin. Rev. Allergy Immunol. 35: 135-153.
6. Joseph, T., D. Look, and T. Ferkol. 2005. NF-kappaB activation and sustained IL-8 gene expression in primary cultures of cystic fibrosis airway epithelial cells stimulated with Pseudomonas aeruginosa. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L471-L479. (Pubitemid 40229512)
7. Blohmke, C. J., R. E. Victor, A. F. Hirschfeld, I. M. Elias, D. G. Hancock, C. R. Lane, A. G. F. Davidson, P. G. Wilcox, K. D. Smith, J. Overhage, et al. 2008. Innate immunity mediated by TLR5 as a novel antiinflammatory target for cystic fibrosis lung disease. J. Immunol. 180: 7764-7773.
8. Blohmke, C. J., J. Park, A. F. Hirschfeld, R. E. Victor, J. Schneiderman, D. Stefanowicz, M. A. Chilvers, P. R. Durie, M. Corey, J. Zielenski, et al. 2010. TLR5 as an anti-inflammatory target and modifier gene in cystic fibrosis. J. Immunol. 185: 7731-7738.
9. Bérubé, J., L. Roussel, L. Nattagh, and S. Rousseau. 2010. Loss of cystic fibrosis transmembrane conductance regulator function enhances activation of p38 and ERK MAPKs, increasing interleukin-6 synthesis in airway epithelial cells exposed to Pseudomonas aeruginosa. J. Biol. Chem. 285: 22299-22307.
10. Mayer, M. L., J. A. Sheridan, C. J. Blohmke, S. E. Turvey, and R. E.W. Hancock. 2011. The Pseudomonas aeruginosa autoinducer 3O-C12 homoserine lactone provokes hyperinflammatory responses from cystic fibrosis airway epithelial cells. PLoS ONE 6: E16246.
11. Xu, Y., A. Krause, H. Hamai, B. G. Harvey, T. S. Worgall, and S. Worgall. 2010. Proinflammatory phenotype and increased caveolin-1 in alveolar macrophages with silenced CFTR mRNA. PLoS ONE 5: E11004.
12. Vij, N., S. Mazur, and P. L. Zeitlin. 2009. CFTR is a negative regulator of NFkappaB mediated innate immune response. PLoS ONE 4: E4664.
13. Fu, L., and E. Sztul. 2009. ER-associated complexes (ERACs) containing aggregated cystic fibrosis transmembrane conductance regulator (CFTR) are degraded by autophagy. Eur. J. Cell Biol. 88: 215-226.
14. Knorre, A., M. Wagner, H. E. Schaefer, W. H. Colledge, and H. L. Pahl. 2002. DeltaF508-CFTR causes constitutive NF-kappaB activation through an ERoverload response in cystic fibrosis lungs. Biol. Chem. 383: 271-282. (Pubitemid 34229129)
15. Chen, J., M. Kinter, S. Shank, C. Cotton, T. J. Kelley, and A. G. Ziady. 2008. Dysfunction of Nrf-2 in CF epithelia leads to excess intracellular H2O2 and inflammatory cytokine production. PLoS ONE 3: E3367.
16. Luciani, A., V. R. Villella, S. Esposito, N. Brunetti-Pierri, D.Medina, C. Settembre, M. Gavina, L. Pulze, I. Giardino, M. Pettoello-Mantovani, et al. 2010. Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition. Nat. Cell Biol. 12: 863-875.
17. Bodas, M., T. Min, and N. Vij. 2011. Critical role of CFTR-dependent lipid rafts in cigarette smoke-induced lung epithelial injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 300: L811-L820.
18. Abdulrahman, B. A., A. A. Khweek, A. Akhter, K. Caution, S. Kotrange, D. H. A. Abdelaziz, C. Newland, R. Rosales-Reyes, B. Kopp, K. McCoy, et al. 2011. Autophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis. Autophagy 7: 1359-1370.
19. Blohmke, C. J., M. L. Mayer, A. C. Tang, A. F. Hirschfeld, C. D. Fjell, M. A. Sze, R. Falsafi, S. Wang, K. Hsu, M. A. Chilvers, et al. 2012. Atypical activation of the unfolded protein response in cystic fibrosis airway cells contributes to p38 MAPK-mediated innate immune responses. J. Immunol. 189: 5467-5475.
20. Scott, M. G., E. Dullaghan, N. Mookherjee, N. Glavas, M. Waldbrook, A. Thompson, A. Wang, K. Lee, S. Doria, P. Hamill, et al. 2007. An antiinfective peptide that selectively modulates the innate immune response. Nat. Biotechnol. 25: 465-472. (Pubitemid 46572850)
21. Nijnik, A., L. Madera, S. Ma, M. Waldbrook, M. R. Elliott, D. M. Easton, M. L. Mayer, S. C. Mullaly, J. Kindrachuk, H. Jenssen, and R. E. W. Hancock. 2010. Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment. J. Immunol. 184: 2539-2550.
22. Wieczorek, M., H. Jenssen, J. Kindrachuk, W. R. P. Scott, M. Elliott, K. Hilpert, J. T. J. Cheng, R. E. W. Hancock, and S. K. Straus. 2010. Structural studies of a peptide with immune modulating and direct antimicrobial activity. Chem. Biol. 17: 970-980.
23. Achtman, A. H., S. Pilat, C. W. Law, D. J. Lynn, L. Janot, M. L. Mayer, S. Ma, J. Kindrachuk, B. B. Finlay, F. S. L. Brinkman, et al. 2012. Effective adjunctive therapy by an innate defense regulatory Peptide in a preclinical model of severe malaria. Sci. Transl. Med. 4: 135ra64.
24. Yu, H. B., A. Kielczewska, A. Rozek, S. Takenaka, Y. Li, L. Thorson R. E. W. Hancock, M. M. Guarna, J. R. North, L. J. Foster, et al. 2009. Sequestosome-1/p62 is the key intracellular target of innate defense regulator peptide. J. Biol. Chem. 284: 36007-36011.
25. Barabási, A. L., N. Gulbahce, and J. Loscalzo. 2011. Network medicine: A network-based approach to human disease. Nat. Rev. Genet. 12: 56-68.
26. Zak, D. E., and A. Aderem. 2009. Systems biology of innate immunity. Immunol. Rev. 227: 264-282.
27. Gardy, J. L., D. J. Lynn, F. S. L. Brinkman, and R. E. W. Hancock. 2009. Enabling a systems biology approach to immunology: Focus on innate immunity. Trends Immunol. 30: 249-262.
28. Mookherjee, N., P. Hamill, J. Gardy, D. Blimkie, R. Falsafi, A. Chikatamarla, D. J. Arenillas, S. Doria, T. R. Kollmann, and R. E. W. Hancock. 2009. Systems biology evaluation of immune responses induced by human host defence peptide LL-37 in mononuclear cells. Mol. Biosyst. 5: 483-496.
29. Darveau, R. P., and R. E. W. Hancock. 1983. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J. Bacteriol. 155: 831-838. (Pubitemid 13048117)
30. Flotte, T. R., S. A. Afione, R. Solow, M. L. Drumm, D. Markakis, W. B. Guggino, P. L. Zeitlin, and B. J. Carter. 1993. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J. Biol. Chem. 268: 3781-3790. (Pubitemid 23071029)
31. Bolstad, B. M., R. A. Irizarry, M. Astrand, and T. P. Speed. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193. (Pubitemid 36181903)
32. Benjamini, Y., and Y. Hochberg. 1995. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Statist. Soc.B 57: 289-300.
33. Falcon, S., and R. Gentleman. 2007. Using GOstats to test gene lists for GO term association. Bioinformatics 23: 257-258. (Pubitemid 46189622)
34. Trapnell, C., L. Pachter, and S. L. Salzberg. 2009. TopHat: Discovering splice junctions with RNA-Seq. Bioinformatics 25: 1105-1111.
35. Robinson, M. D., D. J. McCarthy, and G. K. Smyth. 2010. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26: 139-140.
36. Young, M. D., M. J. Wakefield, G. K. Smyth, and A. Oshlack. 2010. Gene ontology analysis for RNA-seq: Accounting for selection bias. Genome Biol. 11: R14.
37. Lynn, D. J., G. L. Winsor, C. Chan, N. Richard, M. R. Laird, A. Barsky, J. L. Gardy, F. M. Roche, T. H. Chan, N. Shah, et al. 2008. InnateDB: Facilitating systems-level analyses of the mammalian innate immune response. Mol. Syst. Biol. 4: 218.
38. Ho, R. L., and C. A. Lieu. 2008. Systems biology: An evolving approach in drug discovery and development. Drugs R D. 9: 203-216. (Pubitemid 351920120)
39. Pena, O. M., J. Pistolic, D. Raj, C. D. Fjell, and R. E. W. Hancock. 2011. Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells. J. Immunol. 186: 7243-7254.
40. Turner-Brannen, E., K. Y. Choi, D. N. Lippert, J. P. Cortens, R. E. Hancock, H. El-Gabalawy, and N. Mookherjee. 2011. Modulation of interleukin-1b-induced inflammatory responses by a synthetic cationic innate defence regulator peptide, IDR-1002, in synovial fibroblasts. Arthritis Res. Ther. 13: R129.
41. Smoot, M. E., K. Ono, J. Ruscheinski, P. L. Wang, and T. Ideker. 2011. Cytoscape 2.8: New features for data integration and network visualization. Bioinformatics 27: 431-432.
42. Cline, M. S., M. Smoot, E. Cerami, A. Kuchinsky, N. Landys, C. Workman, R. Christmas, I. Avila-Campilo, M. Creech, B. Gross, et al. 2007. Integration of biological networks and gene expression data using Cytoscape. Nat. Protoc. 2: 2366-2382.
43. Lin, C. Y., C. H. Chin, H. H. Wu, S. H. Chen, C. W. Ho, and M. T. Ko. 2008. Hubba: Hub objects analyzer-a framework of interactome hubs identification for network biology. Nucleic Acids Res. 36(Web Server issue): W438-W443.
44. Beisser, D., G. W. Klau, T. Dandekar, T. Muller, and M. T. Dittrich. 2010. BioNet: An R-Package for the functional analysis of biological networks. Bioinformatics 26: 1129-1130.
45. Cerami, E. G., B. E. Gross, E. Demir, I. Rodchenkov, O. Babur, N. Anwar, N. Schultz, G. D. Bader, and C. Sander. 2011. Pathway Commons, a web resource for biological pathway data. Nucleic Acids Res. 39(Database issue): D685-D690.
46. Kabeya, Y., N. Mizushima, T. Ueno, A. Yamamoto, T. Kirisako, T. Noda, E. Kominami, Y. Ohsumi, and T. Yoshimori. 2000. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19: 5720-5728.
47. Corbett, N. P., D. Blimkie, K. C. Ho, B. Cai, D. P. Sutherland, A. Kallos, J. Crabtree, A. Rein-Weston, P. M. Lavoie, S. E. Turvey, et al. 2010. Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells. PLoS ONE 5: E15041.
48. Zeitlin, P. L. 2009. Pseudomonas aeruginosa: Can studies in engineered cells tell us why is it such a problem in people with cystic fibrosis? Focus on "Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa". Am. J. Physiol. Cell Physiol. 297: C235-C237.
49. Ribeiro, C. M. P., A. M. Paradiso, U. Schwab, J. Perez-Vilar, L. Jones, W. O'neal, and R. C. Boucher. 2005. Chronic airway infection/inflammation induces a Ca2+i-dependent hyperinflammatory response in human cystic fibrosis airway epithelia. J. Biol. Chem. 280: 17798-17806. (Pubitemid 41389019)
50. Zaman, M. M., A. Gelrud, O. Junaidi, M. M. Regan, M. Warny, J. C. Shea, C. Kelly, B. P. O'Sullivan, and S. D. Freedman. 2004. Interleukin 8 secretion from monocytes of subjects heterozygous for the deltaF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered. Clin. Diagn. Lab. Immunol. 11: 819-824. (Pubitemid 39280584)
51. Bonfield, T. L., C. A. Hodges, C. U. Cotton, and M. L. Drumm. 2012. Absence of the cystic fibrosis transmembrane regulator (Cftr) from myeloid-derived cells slows resolution of inflammation and infection. J. Leukoc. Biol. 92: 1111-1122.
52. Ogilvie, V., M. Passmore, L. Hyndman, L. Jones, B. Stevenson, A. Wilson, H. Davidson, R. R. Kitchen, R. D. Gray, P. Shah, et al. 2011. Differential global gene expression in cystic fibrosis nasal and bronchial epithelium. Genomics 98: 327-336.
53. Wright, J. M., P. L. Zeitlin, L. Cebotaru, S. E. Guggino, and W. B. Guggino. 2004. Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line demonstrates a major influence on heat-shock proteins. Physiol. Genomics 16: 204-211. (Pubitemid 38420037)
54. Eidelman, O., M. Srivastava, J. Zhang, X. Leighton, J. Murtie, C. Jozwik, K. Jacobson, D. L. Weinstein, E. L. Metcalf, and H. B. Pollard. 2001. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway. Mol. Med. 7: 523-534. (Pubitemid 33701958)
55. Behrends, C., M. E. Sowa, S. P. Gygi, and J. W. Harper. 2010. Network organization of the human autophagy system. Nature 466: 68-76.
56. Klionsky, D. J., H. Abeliovich, P. Agostinis, D. K. Agrawal, G. Aliev, D. S. Askew, M. Baba, E. H. Baehrecke, B. A. Bahr, A. Ballabio, et al. 2008. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4: 151-175. (Pubitemid 351231180)
57. Jager, S., C. Bucci, I. Tanida, T. Ueno, E. Kominami, P. Saftig, and E. L. Eskelinen. 2004. Role for Rab7 in maturation of late autophagic vacuoles. J. Cell Sci. 117: 4837-4848. (Pubitemid 39433449)
58. Tanida, I., N. Minematsu-Ikeguchi, T. Ueno, and E. Kominami. 2005. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy 1: 84-91.
59. Bastonero, S., Y. Le Priol, M. Armand, C. S. Bernard, M. Reynaud-Gaubert, D. Olive, D. Parzy, S. de Bentzmann, C. Capo, and J. L. Mege. 2009. New microbicidal functions of tracheal glands: Defective anti-infectious response to Pseudomonas aeruginosa in cystic fibrosis. PLoS ONE 4: E5357.
60. Colombo, C., D. Costantini, A. Rocchi, L. Cariani, M. L. Garlaschi, S. Tirelli, G. Calori, E. Copreni, and M. Conese. 2005. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy. Pediatr. Pulmonol. 40: 15-21. (Pubitemid 40917903)
61. Saadane, A., J. Soltys, and M. Berger. 2006. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation. J. Allergy Clin. Immunol. 117: 1163-1169.
62. Murphy, B. S., H. M. Bush, V. Sundareshan, C. Davis, J. Hagadone, T. J. Cory, H. Hoy, D. Hayes, Jr., M. I. Anstead, and D. J. Feola. 2010. Characterization of macrophage activation states in patients with cystic fibrosis. J. Cyst. Fibros. 9: 314-322.
63. Shi, C. S., and J. H. Kehrl. 2008. MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages. J. Biol. Chem. 283: 33175-33182.
64. Shi, C. S., and J. H. Kehrl. 2010. TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy. Sci. Signal. 3: Ra42.
65. Yuk, J. M., D. M. Shin, H. M. Lee, C. S. Yang, H. S. Jin, K. K. Kim, Z. W. Lee, S. H. Lee, J. M. Kim, and E. K. Jo. 2009. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 6: 231-243.
66. Ding, W. X., H. M. Ni, W. Gao, T. Yoshimori, D. B. Stolz, D. Ron, and X. M. Yin. 2007. Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am. J. Pathol. 171: 513-524. (Pubitemid 47344684)
67. Lee, Y. K., and O. J. Park. 2010. Regulation of mutual inhibitory activities between AMPK and Akt with quercetin in MCF-7 breast cancer cells. Oncol. Rep. 24: 1493-1497.
68. Achuthan, A., P. Masendycz, J. A. Lopez, T. Nguyen, D. E. James, M. J. Sweet, J. A. Hamilton, and G. M. Scholz. 2008. Regulation of the endosomal SNARE protein syntaxin 7 by colony-stimulating factor 1 in macrophages. Mol. Cell. Biol. 28: 6149-6159.
69. Nair, U., A. Jotwani, J. Geng, N. Gammoh, D. Richerson, W. L. Yen, J. Griffith, S. Nag, K. Wang, T. Moss, et al. 2011. SNARE proteins are required for macroautophagy. Cell 146: 290-302.
70. Moreau, K., B. Ravikumar, M. Renna, C. Puri, and D. C. Rubinsztein. 2011. Autophagosome precursor maturation requires homotypic fusion. Cell 146: 303-317.
71. Hamed, H. A., A. Yacoub, M. A. Park, P. Eulitt, D. Sarkar, I. P. Dimitrie, C. S. Chen, S. Grant, D. T. Curiel, P. B. Fisher, and P. Dent. 2010. OSU-03012 enhances Ad.7-induced GBM cell killing via ER stress and autophagy and by decreasing expression of mitochondrial protective proteins. Cancer Biol. Ther. 9: 526-536.
72. Gangell, C., S. Gard, T. Douglas, J. Park, N. de Klerk, T. Keil, S. Brennan, S. Ranganathan, R. Robins-Browne, and P. D. Sly; AREST CF. 2011. Inflammatory responses to individual microorganisms in the lungs of children with cystic fibrosis. Clin. Infect. Dis. 53: 425-432.
73. Baghaie, N., S. Kalilzadeh, M. Hassanzad, N. Parsanejad, and A. Velayati. 2010. Determination of mortality from cystic fibrosis. Pneumologia 59: 170-173.
74. Schnaith, A., H. Kashkar, S. A. Leggio, K. Addicks, M. Kronke, and O. Krut. 2007. Staphylococcus aureus subvert autophagy for induction of caspaseindependent host cell death. J. Biol. Chem. 282: 2695-2706. (Pubitemid 47076780)
75. Yuan, K., C. Huang, J. Fox, D. Laturnus, E. Carlson, B. Zhang, Q. Yin, H. Gao, and M. Wu. 2012. Autophagy plays an essential role in the clearance of Pseudomonas aeruginosa by alveolar macrophages. J. Cell Sci. 125: 507-515.
76. Renna, M., C. Schaffner, K. Brown, S. Shang, M. H. Tamayo, K. Hegyi, N. J. Grimsey, D. Cusens, S. Coulter, J. Cooper, et al. 2011. Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J. Clin. Invest. 121: 3554-3563.